Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 May 1;19(3):342-345.
doi: 10.1097/ICB.0000000000001558.

BILATERAL CHOROIDAL DETACHMENTS FOLLOWING NOVEL CHIMERIC ANTIGEN RECEPTOR T-CELL IMMUNOTHERAPY REGIMEN

Timothy J Goblirsch  1 , Vincent Huang, Albert Maguire, Apoorv P Chebolu
Affiliations
Case Reports

BILATERAL CHOROIDAL DETACHMENTS FOLLOWING NOVEL CHIMERIC ANTIGEN RECEPTOR T-CELL IMMUNOTHERAPY REGIMEN

Timothy J Goblirsch et al. Retin Cases Brief Rep. .

Abstract

Background/purpose: The aim of this study was to describe a vision-threatening adverse event of a novel chimeric antigen receptor T-cell immunotherapy for metastatic prostate cancer.

Methods: This was an observational case report.

Results: A 77-year-old male patient with a history of metastatic prostate cancer and pulmonary embolism enrolled in a clinical trial investigating the use of chimeric antigen receptor T-cell immunotherapy for treatment of metastatic prostate cancer presented with a subjective left temporal visual disturbance. The patient was found to have bilateral extensive choroidal detachments on examination. Optical coherence tomography macula demonstrated no intraretinal fluid or supraretinal fluid in both eyes. B-scan of both eyes redemonstrated choroidal detachments in both eyes and no retinal detachment in either eye. The patient was initiated on a topical and systemic steroid regimen and experienced symptomatic and clinical improvement.

Conclusion: The authors exhibit a case of bilateral choroidal detachments secondary to systemic reaction to a novel immunotherapy for metastatic cancer successfully treated with systemic and topical steroids. A close follow-up may be required for patients receiving similar novel immunotherapeutic regimens.

Keywords: bilateral choroidal detachments; cancer immunotherapy; serous choroidal effusion.

PubMed Disclaimer

References

    1. June CH, O'Connor RS, Kawalekar OU, et al. CAR T cell immunotherapy for human cancer. Science 2018;359:1361–1365. doi:
    1. Chen YJ, Abila B, Mostafa Kamel YCAR-T. What is next? Cancers (Basel) 2023;15:663.
    1. Jacoby E, Zloto O, Vishnevskia Dai V. Anterior chamber infiltration of CAR T-cells. Am J Ophthalmol Case Rep 2021;24:101223.
    1. Denton CC, Gange WS, Abdel-Azim H, et al. Bilateral retinal detachment after chimeric antigen receptor T-cell therapy. Blood Adv 2020;4:2158–2162.
    1. Zu C, Xu Y, Wang Y, et al. Cytomegalovirus retinitis and retinal detachment following chimeric antigen receptor T cell therapy for relapsed/refractory multiple myeloma. Curr Oncol 2022;29:490–496.

Publication types

Substances

LinkOut - more resources